Running along the lines of Mahavir’s motto of ‘Constant Progression’, this division was created in 2018 to explore, expand and secure new markets such as the Pharmaceutical market. Most of the work done in this division is on laboratory scale yet. Mahavir has been able to commercialise a couple of intermediates for this field. Multiple products are in the pipeline for pharmaceuticals with many of these being multi-substituted aromatic and heterocyclic organic compounds. With acute technical knowledge and intricate operational ability, Mahavir aims to add more products to this division continuously.